John S. Pollack

Impliant, Inc. develops novel spine arthroplasty solutions for motion preservation. The company was founded by Amiram Steinberg and Uri Arnin in 2004 and it is headquartered in Princeton, NJ.

Part of Cornhill Corp. LLP, RDC Communications Ltd. provides wireless telecommunications services. The company is based in Jerusalem, Israel. RDC Communications was acquired by Telent Technology Services Ltd. on July 01, 1999 for $39.31 million.

Galil Medical Ltd. provides cryotheraphy solutions. It offers systematic and needles way of treatment in the areas includes conditions affecting bone, kidney, liver, lung and prostate, as well as targeted pain and nerve applications. The company was founded in 1997 and is headquartered in Yokneam, Israel.

Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI.

Evergreen Venture Partners Ltd (Evergreen Ventures) is a venture capital firm founded in 1987 by Jacob Burak and Ofer Neeman. The firm is headquartered in Tel Aviv, Israel.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities.

Heidelberg Engineering GmbH engages in the design, manufacture, and distribution of diagnostic instruments for eye care professionals. Its products include diagnostic imaging platform, edge perimeter, retina tomography, and ophthalmic image management and device integration platform. It offers products under SPECTRALIS, HEP, HRT, and HEYEX brands. The company was founded by Gerhard Zinser and Christoph Schoess and is headquartered in Heidelberg, Germany.

Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador.

Medingo Ltd. engages in developing a tiny insulin pump that allows people with diabetes to deliver insulin discreetly without tubing or injections. Medingo's product is Solo MicroPump. The company was founded on November 2, 2005 and is headquartered in Tel Aviv, Israel.

RDC - Rafael Development Corp. Ltd. (RDC - Rafael Development Corp) is a private equity/venture capital subsidiary of Elron Ventures Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel.

Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The company is based in Rehovot, Israel. The company was founded by Israel Makov.

CorAssist Cardiovascular Ltd. develops therapeutic products for treating diastolic heart failure. Its proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. The firm’s product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The company was founded by Yair Feld, Yotam Reisner and Shay Dubi in 2003 and is headquartered in Haifa, Israel.

NeuroSonix Ltd. develops and markets non-invasive ultrasound-based embolic protection technology and devices. Its products include EmBlocker, an ultrasonic device, which is used to deflect gaseous and solid emboli during open heart surgeries. The company was founded by Simcha Milo and Nathan Sela in 2002 and is headquartered in Rehovot, Israel.

BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel.

QuantomiX Ltd. develops and markets capsules that enable real-time analysis of wet cells and tissue biopsies. The firm with the its QXTM capsule product line, wet samples, including cells and tissues biopsies, will be able to be examined immediately and accurately. The company's technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment. QuantomiX was founded in March 2001 by Micha Brunstein, Zachy Berger and Ory S. Zik and is headquartered in Rehovot, Israel.

POCARED Diagnostics Ltd. engages in developing diseases diagnostic technologies, with the purpose of optimizing antibiotic stewardship, patient care and laboratory efficiency. Its pipeline includes rapid antimicrobial susceptibility technology. The company was founded by Jonathan Gurfinkel, and Gal Ingber in 2004 and is headquartered in Rehovot, Israel.

Sync-Rx Ltd. develops trans-catheter cardiovascular interventions technology solutions. It focuses on cornory angioplasty and percutaneous valve replacement and repair. The company was founded by David Tolkowsky in 2007 and is headquartered in Netanya, Israel.

CartiHeal Ltd. operates as a medical device company which develops implants for the regeneration of cartilage and bone disorders. Its product includes Agili-C implant which promote regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous agents. The company was founded by Nir Altschuler in 2009 and is headquartered in Kfar Saba, Israel.

Ganot Capital LLC (Ganot Capital) is a private equity/venture capital firm founded in 2009 by Samuel A. Klurman. The firm is headquartered in Hollywood, Florida.

Zoll Medical Israel Ltd. develops patient monitoring solutions for chronic cardiac illnesses. It has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. The firm’s solutions are designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making. The company was founded by y Murali Srivathsa, Uriel Weinstein, Assaf Bernstein, Michal Shohat in 2008 and is headquartered in Kfar Saba, Israel.

coramaze technologies GmbH operates as a medical device company which develops valve repair system. It offers mitramaze a novel concept for transcatheter mitral valve repair intended for treatment of inoperable patients suffering from severe functional mitral regurgitation. The company was founded by Laura Figulla and Till Neumann in 2013 and is headquartered in Munich, Germany.

Nitinotes Ltd. develops advance non-surgical bariatric solutions. The company was founded by Tamir Wolf and Irit Yaniv in 2014 and is headquartered in Ramat Gan, Israel.

Azura Ophthalmics Ltd. develops therapies for meibomian gland dysfunction. It offers a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for meibomian gland dysfunction. The company was founded by Yair Alster in 1980 and is headquartered in Tel Aviv, Israel.

Saiva, Inc. provides health care technology services. The company was founded by Jason Strober and is headquartered in Los Altos, CA.

Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel.

Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ.

Ethos Ventures ( Ethos VC) is a venture capital firm founded in 2020. The firm is headquartered in San Francisco, California.

Part of Notal Vision Ltd., Notal Vision, Inc. develops ophthalmic diagnostic devices. The private company is based in Manassas, VA. The company was founded by Barak Azmon. The CEO is Kester Nahen.

Peer Medical, Inc. is a company that allows cancer patients to share and compare their treatment experiences with other survivors. The company is based in San Francisco, CA and was founded by Ed Spiegel. The company uses electronic medical records to verify users and organize the data, making it easier for patients to find the most relevant information for their care.

RedDress USA, Inc. specializes in providing advanced wound care products and skin substitutes for the treatment of chronic wounds. The company is based in Ponte Vedra Beach, FL. The company's ActiGraft Virtual Training program offers comprehensive training for healthcare providers to begin offering ActiGraft within their healthcare setting. The company was founded in 2009 by Igal Kushnir and Alon Kushnir, with Alon Kushnir serving as the CEO since 2009.